529 / 1631
Rituximab has changed the landscape in
Follicular Lymphoma
•
Watch and wait versus rituximab – is
watch and wait
still the correct
approach ?
•
Rituximab – chemotherapy – what is the
optimal immunochemotherapy
?
•
Rituximab maintenance – is 2 years standard of care and should this be with
subcutaneous Rituximab
?
•
Rituximab
biosimilars
– is this cost effective approach inevitable ?